|
Xenogen (R) Corporation, based in Alameda, California, is known for its VivoVision (R) biophotonic imaging technology, which allows researchers to measure cellular activity or genetic expression. Results can be employed in tracking the progression of disease and evaluating treatments. The firm's Xenogen IVIS (R) Imaging Systems use ultra-sensitive, cryogenically cooled CCD cameras in quantifying emitted photons of tagged cells. The Living Image (R) software allows researchers to control camera, imaging, and data capture operations. LPTA (R) animal models, which emit light when genes are expressed, support real-time in vivo imaging. The firm also is known for its Bioware (R) cells and microorganisms, which are tagged to emit light. The company offers clients pathogenic bacteria and tumor cell lines. Through its Xenogen Biosciences subsidiary, the firm provides biomedical researchers with animal model development services. The wholly owned subsidiary is based in Cranbury, New Jersey. Xenogen serves biotechnology, pharmaceutical, and other organizations across the commercial, academic, and government sectors. The firm's technology is marketed to clients worldwide. The company holds multiple patents on its technologies. Xenogen went public in 2004. It is listed on NASDAQ under the XGEN symbol. The firm employs 160 people.
|
Information Sources, Inc.